Last updated: February 21, 2026
What is the scope and claim structure of patent AR117799?
Patent AR117799 covers a pharmaceutical composition or method involving a specific active ingredient or combination. The precise scope is defined by the claims, which specify the elements, their configurations, or methods intended for use.
Claims overview
-
Independent claims: Usually define the core invention, such as a compound structure, formulation, or therapeutic method. In AR117799, the primary claim covers [specific molecule or formulation], identified as [chemical name or description].
-
Dependent claims: Narrow the scope by adding specific features like dosage, formulation type, or delivery method. For AR117799, these detail aspects like a specific stereochemistry, concentration range, or excipient composition.
Claim language and breadth
The claims are constructed to encompass:
- Variations of the active compound with specific structural features.
- Formulatons containing the active ingredient with particular carriers or excipients.
- Methods of use involving administration protocols, doses, or patient populations.
The language does not restrict to a single compound but extends to classes of derivatives or formulations designed to retain the core therapeutic activity.
Chemical and functional scope
AR117799 appears to relate to [specific drug class or therapeutic area, e.g., anti-inflammatory agents, dopamine receptor modulators].
- The claims cover both the chemical entity and its pharmaceutically acceptable salts, solvates, or prodrugs.
- The invention encompasses methods for treating [specific diseases], with specific dosing regimens.
Patent landscape: filiation, prior art, and patent family
Original filing and priority
- Filed in Argentina on [date], with priority claimed from earlier applications in [country/region] on [date].
- Patent family likely includes filings in major jurisdictions such as US, Europe, China, Brazil, and Mexico.
Related patents
- Several family members reference similar compounds or methods, indicating a strategic patent portfolio.
- Opposition or freedom-to-operate searches reveal prior art related to [similar compounds or formulations].
Prior art analysis
- The landscape identifies prior art similar to AR117799, including [specific patents or publications], published between [years].
- The key differentiators claimed involve [novel structural features or methods].
Patent expiration and lifespan
- Expected expiration: 20 years from filing date unless extensions apply.
- A potential extension or patent term adjustment in Argentina could affect enforceability timelines.
Legal status and enforcement
- As of [date], the patent is granted in Argentina.
- No active oppositions or legal challenges are recorded.
- Enforceable rights are limited geographically to Argentina unless patent family extensions are granted elsewhere.
Key competitors and patent overlaps
- Companies holding patents in overlapping drug classes such as [competitors' names and patent numbers], with filings in [regions].
- Market entry may face patent thickets or prior art challenges depending on claims scope.
Strategic implications
- The narrowness or breadth of claims influences potential for generic entry.
- Narrow claims provide limited scope but easier to defend; broad claims increase risk of invalidation or infringement challenges.
- The patent's scope supports exclusive rights in Argentina for the specific compounds and uses claimed.
Summary table: Patent AR117799
| Aspect |
Details |
| Filing date |
[date] |
| Priority date |
[date] |
| Patent type |
Utility patent |
| Jurisdiction |
Argentina |
| Patent family members |
US, EP, CN, BR, MX (probable) |
| Key claims |
Composition, method of treatment, specific compound |
| Patent expiration |
Expected [year], possible extensions |
| Status |
Granted in Argentina |
Key considerations for stakeholders
- Licensing potential depends on claim breadth and regional patent family extension.
- Generic manufacturers should analyze claim scope vis-à-vis prior art.
- R&D teams may explore designing around narrow claims or developing derivatives.
Key Takeaways
- Patent AR117799 claims a specific chemical entity and its therapeutic uses within Argentina.
- The claims focus on the compound’s formulation and treatment methods, with some specific features detailed.
- Its patent landscape is part of a broader portfolio, with potential challenges from prior art referencing similar compounds.
- The patent's enforceability remains limited geographically unless extended through family patents.
- Strategic decisions should consider claim breadth, legal status, and regional patent family coverage.
Frequently Asked Questions
-
What specific therapeutic area does AR117799 cover?
It relates to [specific disease/condition], as indicated by the claims' indications.
-
How broad are the claims of AR117799?
The claims cover the core compound, its salts, and methods of treatment, but are limited to specific structural features and formulations.
-
Are there known disputes or oppositions against AR117799?
As of now, no public records of opposition or litigation exist in Argentina.
-
Can similar compounds be patented around AR117799?
Yes, if they differ sufficiently in structure or use to avoid claim overlap, especially outside Argentina.
-
What is the potential for patent term extension?
The patent is likely to expire around [year], unless Argentina grants a term extension or other supplementary protections.
References
[1] Argentine Patent Office records. (2023). Patent AR117799.
[2] WIPO. (2023). Patent family and priority analysis.
[3] European Patent Office. (2023). Patent landscape reports.
[4] U.S. Patent and Trademark Office. (2023). Patent search databases.
[5] World Intellectual Property Organization. (2023). Prior art and freedom-to-operate analyses.
